277 related articles for article (PubMed ID: 36707619)
21. [Management of advanced-phase chronic myeloid leukemia].
Kitanaka A
Rinsho Ketsueki; 2016; 57(10):1962-1971. PubMed ID: 27725594
[TBL] [Abstract][Full Text] [Related]
22. The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century.
Barrett AJ; Ito S
Blood; 2015 May; 125(21):3230-5. PubMed ID: 25852053
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Patients With Chronic Phase CML Resistant or Intolerant to Tyrosine Kinase Inhibitors.
Yassine F; Reljic T; Moustafa MA; Iqbal M; Murthy HS; Kumar A; Kharfan-Dabaja MA
Hematol Oncol Stem Cell Ther; 2022 Mar; 15(1):36-43. PubMed ID: 33789163
[TBL] [Abstract][Full Text] [Related]
24. Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.
Hu B; Lin X; Lee HC; Huang X; Tidwell RSS; Ahn KW; Hu ZH; Jabbour E; Verstovsek S; Ravandi F; Garcia-Manero G; Kharfan-Dabaja MA; Hossain NM; Marks DI; Kamble RT; Inamoto Y; Kindwall-Keller T; Saad A; Litzow MR; Savani BN; Hale GA; Bacher U; Gerds AT; Liesveld JL; Ustun C; Olsson RF; Daly A; Grunwald MR; Solh M; DeFilipp Z; Aljurf M; Wirk B; Akpek G; Nishihori T; Cerny J; Seo S; Hsu JW; Champlin R; de Lima M; Alyea E; Popat U; Sobecks R; Scott BL; Kantarjian H; Cortes J; Saber W
Leuk Lymphoma; 2020 Dec; 61(12):2811-2820. PubMed ID: 32662346
[TBL] [Abstract][Full Text] [Related]
25. How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety.
Perrone S; Massaro F; Alimena G; Breccia M
Expert Opin Pharmacother; 2016 Aug; 17(11):1517-26. PubMed ID: 27231757
[TBL] [Abstract][Full Text] [Related]
26. Current perspectives for the treatment of chronic myeloid leukemia.
Aladağ E; Haznedaroğlu İC
Turk J Med Sci; 2019 Feb; 49(1):1-10. PubMed ID: 30761815
[TBL] [Abstract][Full Text] [Related]
27. Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia.
Yong AS; Brissot E; Rubinstein S; Savani BN; Mohty M
Expert Rev Hematol; 2015 Dec; 8(6):785-97. PubMed ID: 26364871
[TBL] [Abstract][Full Text] [Related]
28. Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
Suttorp M; Yaniv I; Schultz KR
Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S115-22. PubMed ID: 21195300
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
Poiré X; Artz A; Larson RA; Kline J; Odenike O; Rich E; Godley L; Stock W; van Besien K
Leuk Lymphoma; 2009 Jan; 50(1):85-91. PubMed ID: 19142796
[TBL] [Abstract][Full Text] [Related]
30. Management of chronic myeloid leukemia in blast crisis.
Saußele S; Silver RT
Ann Hematol; 2015 Apr; 94 Suppl 2():S159-65. PubMed ID: 25814082
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party.
Radujkovic A; Dietrich S; Blok HJ; Nagler A; Ayuk F; Finke J; Tischer J; Mayer J; Koc Y; Sorà F; Passweg J; Byrne JL; Jindra P; Veelken JH; Socié G; Maertens J; Schaap N; Stadler M; Itälä-Remes M; Tholouli E; Arat M; Rocha V; Ljungman P; Yakoub-Agha I; Kröger N; Chalandon Y
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2008-2016. PubMed ID: 31271884
[TBL] [Abstract][Full Text] [Related]
32. Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
DeFilipp Z; Ancheta R; Liu Y; Hu ZH; Gale RP; Snyder D; Schouten HC; Kalaycio M; Hildebrandt GC; Ustun C; Daly A; Ganguly S; Inamoto Y; Litzow M; Szer J; Savoie ML; Hossain N; Kharfan-Dabaja MA; Hamadani M; Reshef R; Bajel A; Schultz KR; Gadalla S; Gerds A; Liesveld J; Juckett MB; Kamble R; Hashmi S; Abdel-Azim H; Solh M; Bacher U; Lazarus H; Olsson R; Cahn JY; Grunwald MR; Savani BN; Yared J; Rowe JM; Cerny J; Chaudhri NA; Aljurf M; Beitinjaneh A; Seo S; Nishihori T; Hsu JW; Ramanathan M; Alyea E; Popat U; Sobecks R; Saber W
Biol Blood Marrow Transplant; 2020 Mar; 26(3):472-479. PubMed ID: 31669399
[TBL] [Abstract][Full Text] [Related]
33. Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase.
Mukherjee S; Kalaycio M
Curr Hematol Malig Rep; 2016 Apr; 11(2):86-93. PubMed ID: 26932346
[TBL] [Abstract][Full Text] [Related]
34. How I treat childhood CML.
Andolina JR; Neudorf SM; Corey SJ
Blood; 2012 Feb; 119(8):1821-30. PubMed ID: 22210880
[TBL] [Abstract][Full Text] [Related]
35. Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Przepiorka D; Khouri I; Thall P; Mehra R; Lee MS; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth AB; Champlin R
Bone Marrow Transplant; 1999 May; 23(10):977-81. PubMed ID: 10373061
[TBL] [Abstract][Full Text] [Related]
36. Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era - forgotten but not gone.
Tang K; Lipton JH
Leuk Lymphoma; 2024 Jun; 65(6):705-714. PubMed ID: 38335007
[TBL] [Abstract][Full Text] [Related]
37. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
Osman AEG; Deininger MW
Blood Rev; 2021 Sep; 49():100825. PubMed ID: 33773846
[TBL] [Abstract][Full Text] [Related]
38. Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.
Chiba A; Toya T; Mizuno H; Tokushige J; Nakamura F; Nakazaki K; Kurokawa M
Int J Hematol; 2018 Dec; 108(6):640-646. PubMed ID: 30078165
[TBL] [Abstract][Full Text] [Related]
39. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
[TBL] [Abstract][Full Text] [Related]
40. Pediatric Chronic Myelogenous Leukemia in T-lineage Blast Crisis: A Reminder in Relevance.
Patel SA; Beck JC
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e707-e708. PubMed ID: 35319509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
